Medical Device News Magazine

Anthony S. Fauci, MD to Deliver Keynote Address During the 2020 American Urological Association Virtual Experience

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

June 11, 2020

Anthony S. Fauci, MD will be the Association’s keynote speaker during American Urological Association (AUA) Live, a component of the Association’s 2020 Virtual Experience. Dr. Fauci’s keynote address will take place on Saturday, June 27, at 11:30 a.m. (ET).

Anthony S. Fauci, MD is one of the most visible faces of the U.S. response to the coronavirus pandemic, the National Institute of Allergy and Infectious Diseases (NIAID) director who will provide an update on COVID-19, as well as the research community’s response to the pandemic.

“We are very excited to welcome Dr. Fauci as part of the 2020 AUA Virtual Experience, and his presentation could not be more timely,” said John D. Denstedt, MD, Secretary of the AUA Board of Directors. “He will set the tone for the important work being done every day to manage COVID-19 and reflect on the impact it has had on the urology community, as well as the broader medical community.”

Dr. Fauci is one of the most prominent members of the White House Coronavirus Task Force and has advised six U.S. Presidents on many domestic and global health issues, including HIV/AIDS for more than three decades. He is the recipient of numerous prestigious awards, including the Presidential Medal of Freedom (the highest honor given to a civilian by the President of the United States).

“To date, there have been more than 7.1 million reported cases of COVID-19 around the world and about 410,000 confirmed deaths,” said Denstedt. “Hearing more from Dr. Fauci about a collaborative approach to the clinical testing, scaling capacity and distribution of candidate vaccines to prevent COVID-19 is important to our members and to promoting the highest standards of clinical care.”

Dr. Fauci has served as the director of the NIAID since 1984 and oversees an extensive research portfolio of basic and applied research to prevent, diagnose, and treat established infectious diseases such as tuberculosis, malaria, respiratory infections, as well as emerging diseases such as Ebola and Zika. Additionally, he supports research on transplantation and immune-related illnesses, including autoimmune disorders, asthma and allergies.

The AUA continues to be a leader in developing innovative, evidence-based quality education for urologists and urologic health care professionals worldwide. Through the AUA Virtual Experience—and other year-round educational offerings—the AUA sets the highest standards for urologic education and provides unparalleled access to groundbreaking research, new guidelines and the latest advances in urologic medicine. Register here.

Medical Device News Magazine
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”